Clinical trials · Kansas
Facioscapulohumeral Muscular Dystrophy clinical trials in Kansas
We’re tracking 3 recruiting facioscapulohumeral muscular dystrophy studies with a site in Kansas — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Kansas
- NCT07038200RecruitingPhase 3
Study of Del-brax (AOC 1020) for People with FSHD
This study tests an experimental medicine called Del-brax (AOC 1020) for people with facioscapulohumeral muscular dystrophy (FSHD). The goal is to see if it can help improve muscle strength and slow the disease. You may be able to join if you have a confirmed FSHD diagnosis and can walk at least 10 meters on your own.
Kansas City, KansasAges 16–70 - NCT06721299RecruitingPhase 1
Testing clenbuterol for muscle health in FSHD
This study tests a medication called clenbuterol to see if it can reduce activity of the DUX4 gene, which is believed to cause muscle damage in FSHD. If you have FSHD type 1 or 2, you may be able to join and help researchers understand if this drug can improve muscle health.
Kansas City, KansasAges 18–75 - NCT06847282Recruiting
Motor skills study for children with FSHD
This study looks at how children with FSHD move and function over time. It uses walking tests and optional MRI scans to understand muscle changes. Your child's participation could help researchers learn more about FSHD progression in kids.
Kansas City, KansasAges 5–17
Where these studies are running in Kansas
Institutions with a site for the recruiting facioscapulohumeral muscular dystrophy studies listed above.
- University of Kansas Medical Center · 2 studies
- Kansas University Medical Center
What taking part in a facioscapulohumeral muscular dystrophy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Facioscapulohumeral Muscular Dystrophy trials in other states
Common questions
- Are there facioscapulohumeral muscular dystrophy clinical trials in Kansas?
- Yes. We're currently tracking 3 recruiting facioscapulohumeral muscular dystrophy studies with a site in Kansas, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a facioscapulohumeral muscular dystrophy study in Kansas?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Kansas to take part?
- Not necessarily. These studies have a site in Kansas, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a facioscapulohumeral muscular dystrophy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New facioscapulohumeral muscular dystrophy studies open in Kansas regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.